BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7657031)

  • 1. Processing of proinsulin by furin, PC2, and PC3 in (co) transfected COS (monkey kidney) cells.
    Vollenweider F; Kaufmann J; Irminger JC; Halban PA
    Diabetes; 1995 Sep; 44(9):1075-80. PubMed ID: 7657031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3.
    Smeekens SP; Montag AG; Thomas G; Albiges-Rizo C; Carroll R; Benig M; Phillips LA; Martin S; Ohagi S; Gardner P
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8822-6. PubMed ID: 1528899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Processing of mutated proinsulin with tetrabasic cleavage sites to mature insulin reflects the expression of furin in nonendocrine cell lines.
    Yanagita M; Hoshino H; Nakayama K; Takeuchi T
    Endocrinology; 1993 Aug; 133(2):639-44. PubMed ID: 8344203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proinsulin processing in the rat insulinoma cell line INS after overexpression of the endoproteases PC2 or PC3 by recombinant adenovirus.
    Irminger JC; Meyer K; Halban P
    Biochem J; 1996 Nov; 320 ( Pt 1)(Pt 1):11-5. PubMed ID: 8947461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinsulin conversion in GH3 cells after coexpression of human proinsulin with the endoproteases PC2 and/or PC3.
    Kaufmann JE; Irminger JC; Mungall J; Halban PA
    Diabetes; 1997 Jun; 46(6):978-82. PubMed ID: 9166668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incomplete processing of proinsulin to insulin accompanied by elevation of Des-31,32 proinsulin intermediates in islets of mice lacking active PC2.
    Furuta M; Carroll R; Martin S; Swift HH; Ravazzola M; Orci L; Steiner DF
    J Biol Chem; 1998 Feb; 273(6):3431-7. PubMed ID: 9452465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence requirements for proinsulin processing at the B-chain/C-peptide junction.
    Kaufmann JE; Irminger JC; Halban PA
    Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):869-74. PubMed ID: 7575420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and clinical implications of proinsulin conversion intermediates.
    Given BD; Cohen RM; Shoelson SE; Frank BH; Rubenstein AH; Tager HS
    J Clin Invest; 1985 Oct; 76(4):1398-405. PubMed ID: 3902891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential cleavage of des-31,32-proinsulin over intact proinsulin by the insulin secretory granule type II endopeptidase. Implication of a favored route for prohormone processing.
    Rhodes CJ; Lincoln B; Shoelson SE
    J Biol Chem; 1992 Nov; 267(32):22719-27. PubMed ID: 1429623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence requirements for processing of proinsulin in transfected mouse pituitary AtT20 cells.
    Taylor NA; Docherty K
    Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):619-22. PubMed ID: 1382412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicted structural alterations in proinsulin during its interactions with prohormone convertases.
    Lipkind G; Steiner DF
    Biochemistry; 1999 Jan; 38(3):890-6. PubMed ID: 9893983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the type 2 proinsulin processing endopeptidase as PC2, a member of the eukaryote subtilisin family.
    Bennett DL; Bailyes EM; Nielsen E; Guest PC; Rutherford NG; Arden SD; Hutton JC
    J Biol Chem; 1992 Jul; 267(21):15229-36. PubMed ID: 1634553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Processing of synthetic pro-islet amyloid polypeptide (proIAPP) 'amylin' by recombinant prohormone convertase enzymes, PC2 and PC3, in vitro.
    Higham CE; Hull RL; Lawrie L; Shennan KI; Morris JF; Birch NP; Docherty K; Clark A
    Eur J Biochem; 2000 Aug; 267(16):4998-5004. PubMed ID: 10931181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate specificity of proinsulin conversion in the constitutive pathway of transfected FAO (hepatoma) cells.
    Vollenweider F; Irminger JC; Halban PA
    Diabetologia; 1993 Dec; 36(12):1322-5. PubMed ID: 8307263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What beta-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin-processing mechanism.
    Rhodes CJ; Alarcón C
    Diabetes; 1994 Apr; 43(4):511-7. PubMed ID: 8138054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processing of mutated proinsulin with tetrabasic cleavage sites to bioactive insulin in the non-endocrine cell line, COS-7.
    Yanagita M; Nakayama K; Takeuchi T
    FEBS Lett; 1992 Oct; 311(1):55-9. PubMed ID: 1397292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential rates of conversion of rat proinsulins I and II. Evidence for slow cleavage at the B-chain/C-peptide junction of proinsulin II.
    Sizonenko SV; Halban PA
    Biochem J; 1991 Sep; 278 ( Pt 3)(Pt 3):621-5. PubMed ID: 1898351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proinsulin endopeptidase substrate specificities defined by site-directed mutagenesis of proinsulin.
    Docherty K; Rhodes CJ; Taylor NA; Shennan KI; Hutton JC
    J Biol Chem; 1989 Nov; 264(31):18335-9. PubMed ID: 2478543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proprotein-processing endoprotease furin decreases regulated secretory pathway-specific proteins in the pancreatic beta cell line MIN6.
    Kayo T; Sawada Y; Suzuki Y; Suda M; Tanaka S; Konda Y; Miyazaki J; Takeuchi T
    J Biol Chem; 1996 May; 271(18):10731-7. PubMed ID: 8631882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR and photo-CIDNP studies of human proinsulin and prohormone processing intermediates with application to endopeptidase recognition.
    Weiss MA; Frank BH; Khait I; Pekar A; Heiney R; Shoelson SE; Neuringer LJ
    Biochemistry; 1990 Sep; 29(36):8389-401. PubMed ID: 2252901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.